Cargando…
Genetics and genomics of radiotherapy toxicity: towards prediction
Radiotherapy is involved in many curative treatments of cancer; millions of survivors live with the consequences of treatment, and toxicity in a minority limits the radiation doses that can be safely prescribed to the majority. Radiogenomics is the whole genome application of radiogenetics, which st...
Autores principales: | West, Catharine M, Barnett, Gillian C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238178/ https://www.ncbi.nlm.nih.gov/pubmed/21861849 http://dx.doi.org/10.1186/gm268 |
Ejemplares similares
-
Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer
por: Kerns, Sarah L., et al.
Publicado: (2016) -
Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity
por: Ahmed, Mahbubl, et al.
Publicado: (2016) -
Exploiting biological and physical determinants of radiotherapy toxicity to individualize treatment
por: Scaife, J E, et al.
Publicado: (2015) -
Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy
por: Kerns, Sarah L, et al.
Publicado: (2019) -
Multi-centre technical evaluation of the radiation-induced lymphocyte apoptosis assay as a predictive test for radiotherapy toxicity
por: Talbot, Christopher J., et al.
Publicado: (2019)